# Sincalide

NDC: 70511-131
Generic name: Sincalide
Labeler / Manufacturer: MAIA Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20221125

FDA application: NDA210850

## Active ingredients

- SINCALIDE: 5 ug/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70511-131"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70511-131
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4149af34-7b3d-4200-9609-ea856b1d6aab